ÍøºìºÚÁÏ

Skip to main content
(352) 273-8740

Ali Ataya, MD : Research

Critical Care Medicine Specialist, Pulmonologist (Lung Specialist)

Photo of Ali Ataya
(352) 273-8740 MyUFÍøºìºÚÁÏ

Research at a glance

Top areas of exploration

  • Dyspnea , 10 publications
  • Pulmonary Alveolar Proteinosis , 4 publications
  • Lymphangioleiomyomatosis , 4 publications
  • Fever , 4 publications

Research activity

122 publications

396 citations

Why is this important?

Active clinical trials

Prosera

The primary objective of the study is to determine the effect of seralutinib on improving exercise capacity in subjects with WHO Group 1 PAH who are FC II or III. The secondary objective for this trial is to determine time to clinical worsening.

Investigator
Ali Ataya
Status
Accepting Candidates
Ages
18 Years - 75 Years
Sexes
All
Hemotag
Investigator
Ali Ataya
Status
Accepting Candidates
ROR-PH-303 (APD811-303)

Study ROR-PH-303, ADVANCE EXTENSION, is an open-label extension (OLE) study for participants with WHO Group 1 PAH who have participated in another Phase 2 or Phase 3 study of ralinepag.

Investigator
Ali Ataya
Status
Accepting Candidates
Ages
18 Years - N/A
Sexes
All

My publications

122 publications

2021

Emerging Medical Therapies for Pulmonary Alveolar Proteinosis

American Journal of Respiratory and Critical Care Medicine

2021

Hoarseness in a Patient with Hydropneumothorax

The American Journal of Medicine

2021

Lung and liver transplantation in patients with alpha-1 antitrypsin deficiency.

Therapeutic advances in chronic disease

•

2021

Macrophage activating syndrome causing decompensated right heart failure.

Respiratory medicine case reports

•

2021

Pulmonary Lymphangitic Carcinomatosis From Renal Cell Carcinoma

Current Problems in Diagnostic Radiology